BioLargo Inc
OTC:BLGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioLargo Inc
OTC:BLGO
|
US |
|
M
|
Max's Group Inc
XPHS:MAXS
|
PH |
|
C
|
Clubhouse Media Group Inc
OTC:CMGR
|
US |
|
Holley Inc
NYSE:HLLY
|
US |
|
M
|
Master-Pack Group Bhd
KLSE:MASTER
|
MY |
|
BRD Klee A/S
CSE:KLEE B
|
DK |
|
Kamakura Shinsho Ltd
TSE:6184
|
JP |
|
Carvana Co
NYSE:CVNA
|
US |
|
Australian Potash Ltd
ASX:APC
|
AU |
|
H
|
Humble Group AB
STO:HUMBLE
|
SE |
|
D
|
Daejoo Inc
KOSDAQ:003310
|
KR |
BioLargo Inc
BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. The company is headquartered in Westminster, California and currently employs 27 full-time employees. The firm invents, develops, and commercializes platform technologies to solve environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds (VOC) control, air quality control and infection control. The company provides sustainable solutions for a range of industries and applications. The Company’s products include Advanced Oxidation System (AOS), Aqueous Electrostatic Concentrator (AEC), CupriDyne Clean industrial odor control product, Clyraguard Personal Protection Spray, and hand sanitizer. The firm provides its products through its subsidiaries, including ONM Environmental, Inc., BioLargo Water, Inc., BioLargo Water Investment Group, Inc., BioLargo Development Corp., BioLargo Engineering, Science & Technologies, LLC and Clyra Medical Technologies, Inc.
BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. The company is headquartered in Westminster, California and currently employs 27 full-time employees. The firm invents, develops, and commercializes platform technologies to solve environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds (VOC) control, air quality control and infection control. The company provides sustainable solutions for a range of industries and applications. The Company’s products include Advanced Oxidation System (AOS), Aqueous Electrostatic Concentrator (AEC), CupriDyne Clean industrial odor control product, Clyraguard Personal Protection Spray, and hand sanitizer. The firm provides its products through its subsidiaries, including ONM Environmental, Inc., BioLargo Water, Inc., BioLargo Water Investment Group, Inc., BioLargo Development Corp., BioLargo Engineering, Science & Technologies, LLC and Clyra Medical Technologies, Inc.
Commercial milestones: Clyra Medical launched commercially (ViaCLYR 510(k) cleared), shipped and was paid for its first stocking order, and received $1.7 million of new capital to support rollout.
PFAS validation: AEC water treatment system installed at Lake Stockholm is in a 12-month monitoring program with the U.S. EPA and New Jersey DEP, providing important third‑party validation.
Battery progress: Cellinity Battery has 4 MOUs, third‑party validation, and is negotiating gigafactory joint ventures (each factory forecasted to generate ~$80M–$90M NOI on ~$170M capex).
Financials headline: 2025 revenue declined to $7.8 million, net loss was $15.2 million, cash ended $3.9 million, and stockholders' equity fell to $1.5 million.
Pooph dispute: BioLargo revoked Pooph's license after $3.85 million went unpaid and filed a federal lawsuit for patent infringement, false advertising, and breach of contract.
Services growth: Engineering/services revenue roughly doubled (from $1.0M to ~$2.0M), partially offsetting product revenue weakness.
Capital posture: Lincoln Park ATM expired and will not be renewed; management intends to pursue a similar facility going forward to provide a financing safety net.
2026 outlook: Management expects an inflection year driven by Clyra national rollout, AEC validation, a Cellinity JV, and new ONM partnerships — all described as catalysts rather than numerical guidance.
